ANKRD49 promotes the invasion and metastasis of lung adenocarcinoma via a P38/ATF-2 signalling pathway.

Lung adenocarcinoma (LUAD) is the most challenging neoplasm to treat in clinical practice. Ankyrin repeat domain 49 protein (ANKRD49) is highly expressed in several carcinomas; however, its pattern of expression and role in LUAD are not known. Tissue microarrays, immunohistochemistry, χ2 test, Spearman correlation analysis, Kaplan-Meier, log-rank test, and Cox's proportional hazard model were used to analyse the clinical cases. The effect of ANKRD49 on the LUAD was investigated using CCK-8, clonal formation, would healing, transwell assays, and nude mice experiment. Expressions of ANKRD49 and its associated downstream protein molecules were verified by real-time PCR, Western blot, immunohistochemistry, and/or immunofluorescence analyses. ANKRD49 expression was highly elevated in LUAD. The survival rate and Cox's modelling analysis indicated that there may be an independent prognostic indicator for LUAD patients. We also found that ANKRD49 promoted the invasion and migration in both in in vitro and in vivo assays, through upregulating matrix metalloproteinase (MMP)-2 and MMP-9 activities via the P38/ATF-2 signalling pathway Our findings suggest that ANKRD49 is a latent biomarker for evaluating LUAD prognosis and promotes the metastasis of A549 cells via upregulation of MMP-2 and MMP-9 in a P38/ATF-2 pathway-dependent manner.

Surgical management of Boerhaave's syndrome with early and delayed diagnosis in adults: a retrospective study of 88 patients.

BACKGROUND: spontaneous esophageal rupture (Boerhaave's syndrome) is a rare and challenging clinical condition. OBJECTIVE: to evaluate the outcome of different surgical treatments for patients with Boerhaave's syndrome with an early diagnosis (< 24 h) and delayed diagnosis (> 24 h), using a retrospective cohort study in a tertiary referral center. PATIENTS AND METHODS: eighty-eight patients with Boerhaave's syndrome who underwent surgical treatment were identified from March 1994 to March 2019 in the First Hospital of Shanxi Medical University. Subsequently, they were retrospectively divided into two groups according to time from symptom onset to diagnosis (group 1, < 24 h, n = 16; group 2, > 24 h, n = 72). Primary suture repair was used in group 1 and reinforcement with a vascular muscle flap was used in group 2, in order to reduce the incidence of fistula. Patients in group 2 were further divided into two subgroups according to reinforcement using diaphragmatic flaps (subgroup 1) or intercostal muscle flaps (subgroup 2). RESULTS: the duration of hospitalization and stay in Intensive Care Unit (ICU) was significantly shorter in group 1 (p = 0.027 and p = 0.001). Group 1 had fewer postoperative esophageal leaks (p = 0.037) compared to group 2. Various aspects were compared in the two subgroups and the differences were not statistically significant (p > 0.05). CONCLUSIONS: it is very important to establish an early diagnosis for patients with Boerhaave's syndrome. Early (< 24 h) and primary suture repair is superior to delayed (> 24 h) primary repair, even for those reinforced with vascular muscle flaps. Furthermore, repair reinforcement with different muscle flaps appears to render similar results for patients with delayed diagnosis.

Size-tunable hydrothermal synthesis of SnS2 nanocrystals with high performance in visible light-driven photocatalytic reduction of aqueous Cr(VI).

SnS(2) nanocrystals with adjustable sizes were synthesized via a hydrothermal method from the aqueous solution of common and inexpensive SnCl(4)·5H(2)O, thioacetamide and citric acid, simply by varying the reaction temperature and reaction time. The structures, Brunauer-Emmett-Teller (BET) specific surface areas and optical properties of the resultant SnS(2) nanocrystals were characterized by X-ray diffraction, transmission electron microscopy, N(2) adsorption/desorption isotherms, and UV-vis diffuse reflectance spectra. Besides, their photocatalytic properties were tested for the reduction of aqueous Cr(VI) under visible light (λ > 420 nm) irradiation. It was found that the photocatalytic activities of SnS(2) nanocrystals in aqueous suspension depended on their synthesis conditions. The product synthesized under suitable hydrothermal conditions (for example, at 150 °C for 12 h) not only showed high visible light-driven photocatalytic activity in the reduction of aqueous Cr(VI), but also showed good photocatalytic stability. Our photocatalytic results suggested that SnS(2) nanocrystals are a promising photocatalyst in the efficient utilization of solar energy for the treatment of Cr(VI)-containing wastewater.

High-performance visible-light-driven SnS2/SnO2 nanocomposite photocatalyst prepared via in situ hydrothermal oxidation of SnS2 nanoparticles.

SnS2/SnO2 nanocomposites with tunable SnO2 contents were prepared via in situ hydrothermal oxidation of SnS2 nanoparticles in 0.375-4.5 mass% H2O2 aqueous solutions at 180 °C for 0-12 h. The structure, composition and optical properties of the as-prepared SnS2/SnO2 nanocomposites were characterized by X-ray diffraction, transmission electron microscopy, high-resolution transmission electron microscopy, Brunauer-Emmett-Teller (BET) surface area analysis, energy-dispersive X-ray spectroscopy, X-ray photoelectron spectroscopy, and UV-vis diffuse reflectance spectra. Furthermore, their photocatalytic properties were tested for the degradation of methyl orange in water under visible light (λ > 420 nm) irradiation. It was found that the as-prepared SnS2/SnO2 nanocomposites with suitable SnO2 content not only demonstrated superior photocatalytic activity to both SnS2 nanoparticles and physically mixed SnS2/SnO2 composite nanoparticles, but also had remarkable photocatalytic stability. The tight attachment of SnO2 nanoparticles to SnS2 nanoparticles, which can facilitate interfacial electron transfer and reduce the self-agglomeration of two components, was considered to play an important role in achieving the high photocatalytic performances exhibited by the as-prepared SnS2/SnO2 nanocomposites.

Polycrystalline bismuth oxide films for development of amperometric biosensor for phenolic compounds.

An attractive biocomposite based on polycrystalline bismuth oxide (BiO(x)) film and polyphenol oxidase (PPO) was proposed for the construction of a mediator-free amperometric biosensor for phenolic compounds in environmental water samples. The phenolic biosensor could be easily achieved by casting the biocomposite on the surface of glassy carbon electrode (GCE) via the cross-linking step by glutaraldehyde. The laboratory-prepared bismuth oxide semiconductor was polymorphism. Its hydrophilicity provided a favorable microenvironment for retaining the biological activity of the immobilized protein. The parameters of the fabrication process and the various experimental variables for the enzyme electrode were optimized. The proposed PPO/BiO(x) biosensor provided a linear response to catechol over a concentration range of 4 x 10(-9)M to 1.5 x 10(-5)M with a dramatically developed sensitivity of 11.3 AM(-1)cm(-2) and a detection limit of 1 x 10(-9)M based on S/N=3. In addition, the PPO/BiO(x) biocomposite was characterized by scanning electron microscope (SEM), Fourier transform infrared spectra (FTIR) and rotating disk electrode voltammetry.

Hydrothermal synthesis and photocatalytic activity of CdO2 nanocrystals.

CdO(2) nanocrystals with different sizes were synthesized via the hydrothermal reaction of 3CdSO(4).8H(2)O and H(2)O(2) in 1.25-6.25 vol.% ammonia solutions at 100-140 degrees C for 12h. The resultant products were characterized by powder X-ray diffraction, transmission electron microscope, thermal gravimetric and differential scanning calorimetry, and UV-vis absorption spectra. It was concluded that the resultant products were pure cubic phase CdO(2) nanocrystals, and they would decompose at temperatures higher than 180 degrees C. In addition, degradation of methyl orange in aqueous solution (20.0mg/l) was carried out with the CdO(2) nanocrystals as photocatalyst under ultraviolet light irradiation. The experimental results showed that even a little amount (0.2g) of as-prepared CdO(2) nanocrystals could catalyze degradation of 500 ml methyl orange solution above 99% after 5h of illumination, and smaller size made for higher photocatalytic activity of CdO(2) nanocrystals.